Sayuri Shirai, former Bank of Japan board member referred to the new policy framework and Japansese QE program during a conference in Tokio. When she was still at BoJ she consistently voted in line with Kuroda but opposed negative rates in January. Her views may be assumed to be more ’honest’ due to her not being a BoJ member any more.
- BoJ bond buying to the tune of 80 trn JPY is unsustainable. Gradual reduction to 60 is needed
- the new framework is in fact an implicit tapering, the new framework is in concept a move towards tapering (this is what the markets feared ahead of the last BoJ meeting and the issue we covered in the currency report on JPY released at that time)
- the new framework is tto complicated, reduces transaprency, may have limited effectiveness, is a source of new riskson the bond market.
This was enough to send USDJPY 0.4 figure lower in a quick manner. SUch rhetoric is also Nikkei (JAP225) negative.
The next meeting is on 31-Oct/1-Nov. Yesterday we got a comment from Masai (actually the first interview since she joined on 30-Jun). She claimed that even if the new projections show more delay in the return of CPI to its goal this will not be a case for more easing. It seems to us that the recent stability of Japanese markets and USDJPY in particular made BoJ members more open to try to set expectations for stabilization of policy (instead of the constant push by markets for more easing).
This article is provided for general information purposes only. Any opinions, analyses, prices or other content is provided for educational purposes and does not constitute investment advice or a recommendation. Any research has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Any information provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it.
Past performance is not necessarily indicative of future results, and any person acting on this information does so entirely at their own risk, we do not accept liability for any loss or damage, including without limitation, any loss of profit, which may arise directly or indirectly from the use of or reliance on such information.